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Use of a modified N-nitrosoproline test to show intragastric nitrosation
in patients at risk of gastric cancer
P.W.J. Houghton', S. Leach2, R.W. Owen2, N.J. McC. Mortensenl*, M.J. Hill2
& R.C.N. WilliamsonIt
'University Department of Surgery, Bristol Royal Infirmary, Bristol BS2 8HW, UK; and 2PHLS Centre for Applied
Microbiology and Research, Porton Down, Salisbury, Wilts., UK.
Summary Intragastric nitrosation has been implicated in the pathogenesis of gastric cancer and in
precancerous conditions such as pernicious anaemia and the post-gastrectomy state. Intragastric nitrosation
was assessed in at-risk patients by N-nitrosoproline (NPRO) excretion using both a conventional and a
modified test. Twenty-four hour urinary excretion of NPRO was measured after oral administration of
sodium nitrate (300 mg) and L-proline (500 mg) as an indirect indicator of intragastric nitrosation. In the
conventional test no differences in intragastric nitrosation were found between at-risk patients and controls.
In the modified test the loading dose of sodium nitrate was omitted and urinary NPRO levels were found to
be significantly increased in Polya partial gastrectomy patients (P = 0.003) and post-vagotomy patients
(P = 0.03) compared to controls. In pernicious anaemia patients NPRO levels were also higher than in
controls but just failed to reach statistical significance. This study has confirmed that hypochlorhydria results
in increased intragastric nitrosation, thus facilitating the formation of potentially carcinogenic N-nitroso
compounds.
Intragastric nitrosation may generate carcinogenic N-nitroso
compounds responsible for the development of gastric cancer
(Correa et al., 1975). Epidemiological studies have shown an
increased incidence of gastric cancer in areas with high
nitrate concentrations in water and soil (Hill et al., 1973;
Cuello et al., 1976; Haenszel et al., 1976) and clinical studies
have shown increased intragastric nitrite levels in at-risk
patients such as those with previous gastrectomy (Jones et
al., 1978; Schlag et al., 1980) or pernicious anaemia
(Bartholomew et al., 1980). Hypochlorhydria encourages
intragastric bacterial proliferation (Ruddell et al., 1976);
intraluminal bacteria (Reed et al., 1981) and nitrite
(Muscroft et al., 1981; Stockbrugger et al., 1982; Milton-
Thompson et al., 1982) increase directly with gastric pH.
The aetiological role of N-nitroso compounds, the end
products of nitrosation, remains controversial. Increased
levels of N-nitroso compounds have been reported after
Billroth II (Polya) resection (Schlag et al., 1980; Reed et al.,
1981) and vagotomy (Reed et al., 1981), in patients with
pernicious anaemia (Reed et al., 1981) and in those treated
with cimetidine (Stockbrugger et al., 1982) or omeprazole
(Sharma et al., 1984). Other workers, however, have not
confirmed these findings (Muscroft et al., 1981; Milton-
Thompson et al., 1982; Keighley et al., 1984). The discre-
pancy may reflect methodological differences, for example in
the sampling and collection of gastric juice and the analysis
of N-nitroso compounds (Clark et al., 1985). Most studies
finding increased levels of N-nitroso compounds have used
the method of Walters et al., (1978) in analysis, while those
finding no such increases have used the method of Bavin et
al. (1982).
Intragastric nitrosation may be assessed indirectly by
measuring N-nitrosoproline (NPRO), which is excreted
unchanged in the urine (Ohshima & Bartsch, 1981). In
theory, this method avoids the difficulties involved in gastric
juice sampling and analysis. The aim of this study was to
measure intragastric nitrosation in at-risk subjects by the
indirect method of Ohshima and Bartsch in an attempt to
verify or refute the nitrosamine hypothesis of gastric
carcinogenesis.
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Materials and methods
Ethical Committee approval was obtained for the study
Conventional NPRO test
Eleven controls and 35 patients were studied (Table I). All
the participants in the study were either inpatients or
outpatients, eating normal diets, and no restrictions were
made on their diets beforehand. The controls had no known
history of gastric disease. There were 14 patients who had
undergone vagotomy, with or without pyloroplasty. Twelve
patients had undergone Polya partial gastrectomy and nine
patients had pernicious anaemia.
Subjects were asked not to eat from midnight before the
test. Liquids were allowed for breakfast, and at 09.00h they
were given 300mg sodium nitrate in aqueous solution to
drink. Half an hour later they were given 500mg of L-
proline in aqueous solution. Thereafter they were asked to
refrain from eating and drinking for 2h and smoking for 4h.
At the end of this period they were allowed to eat and drink
normally but were asked to avoid eating smoked meat and
fish and to avoid drinking beer (substances assumed to be
high in natural nitrosoproline). Urine was collected over the
24-h period in a 3-litre bottle containing 10g sodium hydrox-
ide. At the end of the test period the volume of urine
collected was measured and 50ml was taken for analysis of
N-nitrosoproline content. Oamples were stored at -20C until
analysis, which was undertaken within 3 months to prevent
artefactual nitrosamine formation.
Following the completion of this phase of the study a
modified test was performed on many of the same patients
and on others drawn from the gastric follow up clinic.
Further controls were obtained form in- and outpatients.
The modification involved omitting the oral dose of sodium
nitrate.
Modified NPRO test
Twenty controls and 35 patients were studied (Table I). Nine
patients had undergone vagotomy, with or without pyloro-
plasty, 15 patients had undergone Polya partial gastrectomy
and 11 patients had pernicious anaemia.
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Table I Details of patients in the conventional and modified NPRO tests
Urine
Median timefrom (m124h- )
Study group n M:F Median age Range operation/diagnosis (years) Range (years) Smokers median (range)
Conventional NPRO test. Patient details
Controls 11 92 58 32-69 - 4 1,575 (1,200-2,250)
Vagotomy 14 122 55 37-75 7 0.5-22 6 1,825 (1,100-2,800)
Partial gastrectomy 12 93 62 41-77 10 0.5-36 4 1,450 (800-2,050)
Pernicious anaemia 9 54 60 28-80 6 0.5-15 3 1,300 (850-2,100)
Modified NPRO test. Patient details
Controls 20 128 62 35-82 - 6 1,600 (1,050-2,800)
Vagotomy 9 72 58 44-68 8 1-22 3 1,250 (850-1,950)
Partial gastrectomy 15 105 61 41-74 13 0.5-36 5 1,500 (925-2,700)
Pernicious anaemia 11 65 65 43-75 7 1-15 4 1,125 (800-2,400)
Analysis of samples Results
Nitrate was not analysed. The method of NPRO analysis
was similar to that described by Ohshima et al. (1982). After
thawing, ammonium sulphamate, (dissolved in 3.6NH2SO4),
sodium chloride and N-nitrosopipecolic acid (NPIC), as an
internal standard, were added to 7.5ml urine. After extrac-
tion three times with 20ml methanol/dichloromethane mix-
ture (1:9 v/v), the solvent-phase extract was dried through a
column of anhydrous sodium sulphate and concentrated to
dryness in a rotary evaporator. The residue was resuspended
in diethyl ether, and diazomethane was bubbled through the
solution to prepare methyl esters of NPRO and NPIC. After
reducing the volume the sample was analysed using a gas
chromatograph coupled with a thermal energy analyser
(TEA Model 610 Nitrogen Analyser), specific for N-nitroso
compounds. The gas chromatograph (Pye 104) was fitted
with a 2 M x 2mm silanised glass column packed with 5%
FFAP on Chromosorb WaHP (mesh 80-100) with nitrogen
as carrier gas (20-30mlmin-1). The injector temperature was
200°C, the oven temperature 180°C, the interface 175°C and
the pyrolyser 475°C. Statistical analysis of the results was by
Kruskal-Wallis analysis of variance and the Mann-Whitney
U test.
Conventional test
Median NPRO levels in the urine were 2.9,g 24h-1 (range
1.7-11.8pg) in controls, 3.7 g 24h-1 (0.6-22.3pg) in vago-
tomy patients, 2.1 ug 24-1 (0.2-14.5Mg) in partial gastrec-
tomy patients and 3.8Mg 24h-1 (1.3-8.1jg) in pernicious
anaemia patients. None of these differences achieved statisti-
cal significance. (See Figure 1.)
Modified test
Median urinary NPRO levels were significantly higher in
partial gastrectomy patients (median 2.62Mg 24h-1, range
0.29-9.18 g 24h-1; P=0.003) and post-vagotomy patients
(median 1.75jug 24h-1, range 1.1-9.1jg 24h-1; P=0.03)
compared to controls (median 0.93jg 24h-1, range
0-4.86jg 24h-1). In pernicious anaemia patients NPRO
levels were also higher (median 1.44jg 24h-1, range
0-9.15jg 24h-1) than in controls but just failed to reach
statistical significance. (See Figure 2.)
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Figure 1 Conventional NPRO test. Twenty-four hour urinary
excretion of NPRO. Median levels, n.s. = not significant.
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Figure 2 Modified NPRO test. Twenty-four hour urinary
excretion of NPRO. Median levels, n.s. = not significant.
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Discussion
A simple, indirect method of estimating intragastric nitrosa-
tion was chosen to overcome the problems associated with
the collection, storage and measurement of intragastric N-
nitroso compounds. Using the original method of Ohshima
and Bartsch the first part of this study failed to demonstrate
that post-gastric surgical patients, allegedly at increased risk
of gastric cancer, had higher rates of intragastric nitrosation
than normal controls. This finding has recently been con-
firmed by this group of workers (Bartsch et al., 1984; Crespi
et al., 1987) and also independently by Hall et al. (1987).
Two different types of intragastric nitrosation are thought
to occur: first, an acid-mediated reaction which occurs in the
normal stomach (Sander, 1967; Alam et al., 1971; Braunberg
& Dailey, 1973); and second, a bacterial nitrosation which
occurs in the hypochlorhydric stomach (Cuello et al., 1976).
In the normal acidic stomach gastric juice contains very low
concentrations of nitrite, and thus the potential for nitrosa-
tion is extremely low. In the conventional N-nitrosoproline
test, the enormous oral dose of sodium nitrate floods the
stomach with nitrite, which is produced in the salivary
glands and swallowed in the saliva. Gastric concentrations of
nitrite are several orders of magnitude higher than normal
and could selectively enhance the powerful acid-mediated
chemical nitrosation that occurs in the normal stomach. The
artificially high level of nitrosation in controls might thus
obscure any lesser differences. When sodium nitrate was
withheld increased intragastric nitrosation was indeed
observed in the at-risk groups compared to controls.
The N-nitrosoproline test appears to be a valid method for
assessing intragastric nitrosation (Hall et al., 1987), but it
may not provide an entirely accurate representation of
events. The urinary excretion of N-nitrosoproline is known
to vary between normal subjects. These fluctuations are
probably due to variations in gastric pH (Wagner et al.,
1985), since the endogenous nitrosation of proline is highly
pH-dependent with an optimum pH of 2.5 (Mirvish et al.,
1973).
Although NPRO has been shown to be non-carcinogenic
in animal studies, (Mirvish et al., 1980) it was considered
ethically unacceptable to perform the test too frequently on
one patient. We were therefore unable to determine the
variability of the test, though with the numbers of patients
used this factor seems unlikely to have influenced the results.
Furthermore, Bartsch et al. (1984) noted only modest varia-
tions in NPRO excretion in one subject over a 2-year period.
Because cigarette smoking may increase NPRO excretion
(Ladd et al., 1984), patient selection ensured that the number
of smokers was similar in each group, and patients were
asked to refrain from smoking at the beginning of the test
period when nitrosation was assumed to be maximal.
In conclusion, a modification of the N-nitrosoproline test
has shown evidence of increased intragastric nitrosation in
at-risk patients and therefore supports the nitrosamine
hypothesis of gastric carcinogenesis.
This work was supported by the Cancer Research Campaign.
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